Drug Profile


Alternative Names: Dermofural; G-1

Latest Information Update: 02 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Centro de Bioactivos Quimicos
  • Developer CBQYM (CEASED)
  • Class Antibacterials; Antifungals; Small molecules
  • Mechanism of Action DNA inhibitors; Protein synthesis inhibitors; RNA inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Eye disorders; Mycoses

Most Recent Events

  • 10 Apr 2007 No development reported - Phase-II for Eye disorders in Cuba (Topical)
  • 10 Apr 2007 No development reported - Phase-III for Mycoses in Cuba (Topical)
  • 12 Jun 2002 G1 is available for licensing [http://www.cbqym.com]
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top